Sobi, a global leader in specialty care for rare diseases and immunology, and Soficopharm Pharmaceuticals, one of the Egyptian companies with extensive experience in delivering innovative pharmaceutical solutions, announced the signing of a new collaboration agreement aimed at supporting the state’s efforts to provide advanced treatments and enhance the quality of healthcare delivered to patients with rare diseases in Egypt
Sobi and Soficopharm sign an agreement to provide the latest treatments for rare diseases in Egypt
